GLP-1 and methods for treating diabetes

Details for Australian Patent Application No. 2003243929 (hide)

Owner Zealand Pharma A/S

Inventors Steiness, Eva

Agent Shelston IP

Pub. Number AU-B-2003243929

PCT Number PCT/DK03/00463

PCT Pub. Number WO2004/005342

Priority 60/393,917 04.07.02 US; 60/465,613 24.04.03 US

Filing date 2 July 2003

Wipo publication date 23 January 2004

Acceptance publication date 4 June 2009

International Classifications

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61K 38/31 (2006.01) Medicinal preparations containing peptides - Somatostatins

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/393,917 04.07.02 US; 60/465,613 24.04.03 US

11 March 2004 Application Open to Public Inspection

  Published as AU-B-2003243929

4 June 2009 Application Accepted

  Published as AU-B-2003243929

1 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003243930-PHARMACEUTICAL COMPOSITION COMPRISING (S)-(+)-3-(1-(2-(1-ACETYL-2,3-DIHYDR O1H-INDOL-3-YL)ETHYL)-1,2,3,6-TETR AHYDROPYRIDIN4-YL)-6-CHLORO-1H-INDOLE

2003243928-Treatment of dough with a lipoxygenase and a lipolytic enzyme